Jong Rho
Neurology with Special Qualifications in Child Neurology · New Haven, CTNPI 1235243999
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Eisai Inc. at 43.3% of the total. Reporting peaked in 2020 at $19,236 and has fallen 98.4% since, to $311 in 2025. Among neurology with special qualifications in child neurology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $461.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$24K
- Aquestive Therapeutics, Inc.$14K
- Mallinckrodt Hospital Products Inc.$9K
- Biocodex, Inc.$3K
- Otter Pharmaceuticals, LLC$2K
- Dr.reddy's Laboratories,inc.$1K
- plus $3K from 15 others
What the payments were for
- Consulting fees$25,32946%
- Speaking & faculty fees$21,56539%
- Travel & lodging$4,3168%
- Food & beverage$3,7587%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 29 | $23,778 |
| Aquestive Therapeutics, Inc. | 16 | $13,619 |
| Mallinckrodt Hospital Products Inc. | 6 | $8,711 |
| Biocodex, Inc. | 4 | $3,401 |
| Otter Pharmaceuticals, LLC | 1 | $1,674 |
| Dr.reddy's Laboratories,inc. | 1 | $1,000 |
| UCB, Inc. | 12 | $535 |
| Neurelis, Inc. | 12 | $519 |
| SK Life Science, Inc. | 4 | $487 |
| Jazz Pharmaceuticals Inc. | 7 | $413 |
| Sunovion Pharmaceuticals Inc. | 9 | $349 |
| Livanova USA, Inc. | 4 | $179 |
| Biomarin Pharmaceutical Inc. | 3 | $61 |
| Greenwich Biosciences, Inc. | 2 | $52 |
| PTC Therapeutics, Inc. | 2 | $45 |
| Immedica Pharma US, Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| CSL Behring | 1 | $19 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,968 in reported general payments places this provider in the 95th percentile of 28 neurology with special qualifications in child neurology providers in Connecticut.
See all neurology with special qualifications in child neurology providers in Connecticut →
Other neurology with special qualifications in child neurology in New Haven
- Lauren Beslow KayeNew Haven$5K
- David MandelbaumNew Haven$2K
- Kathryn McVicarNew Haven$2K
- Vinita KnightNew Haven$2K
- Dayna PerkowskiNew Haven$768
- Dillon ChenNew Haven$487
- Abdelrahman AlsherbiniNew Haven$365
- Haiyan HuangNew Haven$161
- Harvey BennettNew Haven$157
- Shilpa DassNew Haven$103
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.